
Targeted therapy shows promise in advanced colorectal cancer
A targeted antibody therapy combined with standard chemotherapy has shown early signs of tumour shrinkage and disease control in patients with advanced bowel cancer. This is according to new Phase I clinical trial results from The Institute of Cancer Research, London and The Royal Marsden NHS Foundation… Read More














